84 related articles for article (PubMed ID: 10732866)
1. Flow cytometry of p53 protein expression in some hematological malignancies.
Koníková E; Kusenda J; Babusíková O
Neoplasma; 1999; 46(6):368-76. PubMed ID: 10732866
[TBL] [Abstract][Full Text] [Related]
2. P53 protein expression in human leukemia and lymphoma cells.
Koníková E; Kusenda J
Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
5. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
6. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
[TBL] [Abstract][Full Text] [Related]
9. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.
Klobusická M; Kusenda J; Babusíkova O
Neoplasma; 2001; 48(6):489-95. PubMed ID: 11949843
[TBL] [Abstract][Full Text] [Related]
11. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
12. p53 flow cytometry evaluation in leukemias: correlation to factors affecting clinical outcome.
Cavalcanti GB; Scheiner MA; Simões Magluta EP; Vasconcelos FC; Klumb CE; Maia RC
Cytometry B Clin Cytom; 2010 Jul; 78(4):253-9. PubMed ID: 20198607
[TBL] [Abstract][Full Text] [Related]
13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of p53 and MDM2 proteins in hematological malignancies.
Koníková E; Kusenda J
Neoplasma; 2003; 50(1):31-40. PubMed ID: 12687276
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
16. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
Aswald JM; Wang XH; Aswald S; Lutynski A; Minden MD; Messner HA; Keating A
Cytometry B Clin Cytom; 2006 Nov; 70(6):379-90. PubMed ID: 16977635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]